MX2017003011A - Metodo para usar derivado de acido hidroxamico novedoso y sustancia antibacterial en combinacion. - Google Patents

Metodo para usar derivado de acido hidroxamico novedoso y sustancia antibacterial en combinacion.

Info

Publication number
MX2017003011A
MX2017003011A MX2017003011A MX2017003011A MX2017003011A MX 2017003011 A MX2017003011 A MX 2017003011A MX 2017003011 A MX2017003011 A MX 2017003011A MX 2017003011 A MX2017003011 A MX 2017003011A MX 2017003011 A MX2017003011 A MX 2017003011A
Authority
MX
Mexico
Prior art keywords
acid derivative
hydroxamic acid
combination
hydroxy
antibacterial substance
Prior art date
Application number
MX2017003011A
Other languages
English (en)
Inventor
Eto Maki
Funatsu Tori
Nakagawa Akiko
Fujiwara Masasuke
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of MX2017003011A publication Critical patent/MX2017003011A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones farmacológicas que contienen un derivado de ácido hidroxámico seleccionado de (2S)-2-((4-((4-(1S)-1,2-dihidroxietil) fenil)etinil)benzoil) (metil)amino)-N-hidroxi-N´,2-dimetilmalonami da, (2S)-2-((4-((4-(1R)-1,2-dihidroxietil)fenil)etinil)benzoil) (metil)amino)-N-hidroxi-N´, 2-dimetilimalonamida y (2S)-N-hidroxi-2-((4-((4-((1S)-1-hidroxi-2-metoxietil)fenil)etini l)benzoil) (metil)amino)-N´, 2-dimetilmalonamida o una sal de los derivados y una sustancia antibiótica son útiles en el tratamiento de infecciones bacterianas Gramnegativas.
MX2017003011A 2014-09-12 2015-09-11 Metodo para usar derivado de acido hidroxamico novedoso y sustancia antibacterial en combinacion. MX2017003011A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014186569 2014-09-12
PCT/JP2015/075778 WO2016039432A1 (ja) 2014-09-12 2015-09-11 新規なヒドロキサム酸誘導体および抗菌性物質を組み合わせて使用する方法

Publications (1)

Publication Number Publication Date
MX2017003011A true MX2017003011A (es) 2017-05-30

Family

ID=55459176

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003011A MX2017003011A (es) 2014-09-12 2015-09-11 Metodo para usar derivado de acido hidroxamico novedoso y sustancia antibacterial en combinacion.

Country Status (14)

Country Link
US (1) US10123990B2 (es)
EP (1) EP3192505A4 (es)
JP (1) JPWO2016039432A1 (es)
KR (1) KR20170047390A (es)
CN (1) CN106794162A (es)
AU (1) AU2015316400A1 (es)
BR (1) BR112017004796A2 (es)
CA (1) CA2960936A1 (es)
IL (1) IL250884A0 (es)
MX (1) MX2017003011A (es)
RU (1) RU2017112303A (es)
SG (1) SG11201701955UA (es)
WO (1) WO2016039432A1 (es)
ZA (1) ZA201701770B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200308105A1 (en) * 2016-03-31 2020-10-01 Fujifilm Toyama Chemical Co., Ltd. Novel method for producing hydroxamic acid derivative, and intermediate therefor
CN109415302A (zh) * 2016-03-31 2019-03-01 富士胶片富山化学株式会社 新的异羟肟酸衍生物的晶体、其制造方法及医药用组合物
US10085999B1 (en) 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
CA3077474A1 (en) 2017-10-02 2019-04-11 Arixa Pharmaceuticals, Inc. Aztreonam derivatives and uses thereof
JP7437847B2 (ja) 2018-10-01 2024-02-26 アリクサ ファーマシューティカルズ、インコーポレイテッド レレバクタムの誘導体およびその使用
JP2022524118A (ja) 2019-03-12 2022-04-27 アリクサ ファーマシューティカルズ、インコーポレイテッド アビバクタム誘導体の結晶形
US11565999B2 (en) 2019-04-25 2023-01-31 Arixa Pharmaceuticals, Inc. Methods of synthesizing aztreonam derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101145252B1 (ko) 2003-01-08 2012-05-24 유니버시티 오브 워싱톤 항균제
EP1963262A2 (en) 2005-12-15 2008-09-03 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
EP2662353A3 (en) 2007-06-12 2014-04-02 Achaogen, Inc. Antibacterial agents
JP2011529964A (ja) 2008-08-04 2011-12-15 シェーリング コーポレイション 抗菌剤としての尿素誘導体
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
CA2735929C (en) 2008-09-19 2013-12-17 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
TR201908891T4 (tr) * 2010-04-20 2019-07-22 Fujifilm Toyama Chemical Co Ltd Yeni̇ hi̇droksami̇k asi̇t türevi̇
WO2013170165A1 (en) 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
DK2975022T3 (da) * 2013-03-15 2019-07-15 Fujifilm Toyama Chemical Co Ltd Hidtil ukendt hydroxaminsyrederivat eller salt deraf

Also Published As

Publication number Publication date
BR112017004796A2 (pt) 2017-12-12
SG11201701955UA (en) 2017-04-27
RU2017112303A (ru) 2018-10-12
EP3192505A1 (en) 2017-07-19
CA2960936A1 (en) 2016-03-17
RU2017112303A3 (es) 2019-04-19
IL250884A0 (en) 2017-04-30
EP3192505A4 (en) 2018-04-25
ZA201701770B (en) 2018-08-29
CN106794162A (zh) 2017-05-31
US20170296503A1 (en) 2017-10-19
US10123990B2 (en) 2018-11-13
WO2016039432A1 (ja) 2016-03-17
JPWO2016039432A1 (ja) 2017-06-22
AU2015316400A1 (en) 2017-04-06
KR20170047390A (ko) 2017-05-04

Similar Documents

Publication Publication Date Title
MX2017003011A (es) Metodo para usar derivado de acido hidroxamico novedoso y sustancia antibacterial en combinacion.
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
PH12016501813A1 (en) 1,3-benzodioxole derivative
PH12016502436A1 (en) Anti-infective compounds
TW201613568A (en) Pharmaceutical composition comprising novel hydroxamic acid derivative or salt thereof
MX2021000189A (es) Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
WO2016100578A3 (en) Antimicrobial polymyxins for treatment of bacterial infections
PH12015501588A1 (en) Compounds and methods for treating bacterial infections
WO2015024010A3 (en) Substituted hydroxamic acid compounds
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
MX2017009094A (es) Derivado de polimixina y usos del mismo.
PH12018500358A1 (en) Compounds for use in an antibacterial applications
WO2017218922A8 (en) Compositions and methods for the treatment of bacterial infections
BR112018074985A2 (pt) composições antibacterianas
EP4286001A3 (en) Benzoylglycine derivatives and methods of making and using same
PH12019502509A1 (en) Compounds and methods for treating bacterial infections
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
GEP20217258B (en) 2-homopiperazine-1-yl-4h-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides
ZA201904033B (en) Pharmaceutical compounds
EP3778609A4 (en) NEW PENAM DERIVATIVES OR SALTS THEREOF, ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND USE
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
MX2019010112A (es) Compuestos antibacterianos.
EP3609326A4 (en) COMPOSITION FOR THE DISINFECTION OF SURFACES WITH BACTERIA CAUSING TUBERCULOSIS
BR112018077281A2 (pt) novos antibióticos